These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 25085708

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M, Kenealy M, Johnstone R, Rasheed W, Prince HM.
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [Abstract] [Full Text] [Related]

  • 3. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM, Valdespino-Castillo VE.
    Cir Cir; 2012 Oct; 80(5):470-80. PubMed ID: 23351455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Epigenetics and oncology.
    Mummaneni P, Shord SS.
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS, Sidik SM, Mahmud R, Stanslas J.
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L, Duan YT, Lu P, Zhang ZJ, Zheng XK, Wang JL, Feng WS.
    Curr Top Med Chem; 2018 May; 18(28):2395-2419. PubMed ID: 30582481
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Small Molecular Inhibitors Targeting Chromatin Regulating Proteins for Cancer.
    Luan J, Chu Z, Chandra J, Zhang P.
    Curr Protein Pept Sci; 2016 May; 17(5):455-62. PubMed ID: 26796303
    [Abstract] [Full Text] [Related]

  • 17. [Histone methyltransferases: a new class of therapeutic targets in cancer treatment?].
    Chaib H, Prébet T, Vey N, Collette Y.
    Med Sci (Paris); 2011 May; 27(8-9):725-32. PubMed ID: 21880260
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HDAC modulation and cell death in the clinic.
    Dell'Aversana C, Lepore I, Altucci L.
    Exp Cell Res; 2012 Jul 01; 318(11):1229-44. PubMed ID: 22336671
    [Abstract] [Full Text] [Related]

  • 20. Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
    Petta V, Gkiozos I, Strimpakos A, Syrigos K.
    Cancer Chemother Pharmacol; 2013 Nov 01; 72(5):935-52. PubMed ID: 24036844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.